Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2017-04-14
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing
NCT03341559
Diabetic Foot Ulcer Imaging- Study 2
NCT03942081
Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology
NCT05968924
Photoacoustic Imaging of Foot Wound
NCT07216599
Measurement of Blood Perfusion in Response to Loading in Patients With Wounds
NCT02082041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0
Control - no diabetes
SFDI Imaging
Imaging with SFDI device
1
Diabetes
SFDI Imaging
Imaging with SFDI device
2
Diabetes w/neuropathy
SFDI Imaging
Imaging with SFDI device
3
Diabetes with vascular disease
SFDI Imaging
Imaging with SFDI device
4
Diabetes w/healed ulcer
SFDI Imaging
Imaging with SFDI device
5
Diabetes with current ulcer
SFDI Imaging
Imaging with SFDI device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SFDI Imaging
Imaging with SFDI device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Rheumatoid arthritis
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Modulated Imaging Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kalvin Yu, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11150
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.